| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ADMA BIOLOGICS, INC. | Director | Common Stock | 83.9K | $442K | $5.26 | 26 Feb 2024 | Direct |
| ADMA BIOLOGICS, INC. | Director | Stock Option (right to buy) | 37.5K | $137K | $3.66 | 26 Feb 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ADMA | ADMA BIOLOGICS, INC. | 26 Feb 2024 | 2 | $0 | 4 | Director | 28 Feb 2024, 21:00 |
| ADMA | ADMA BIOLOGICS, INC. | 22 Aug 2023 | 1 | -$5.54M | 4 | Director | 23 Aug 2023, 21:30 |
| ADMA | ADMA BIOLOGICS, INC. | 06 Mar 2023 | 2 | $0 | 4 | Director | 08 Mar 2023, 20:30 |
| ADMA | ADMA BIOLOGICS, INC. | 07 Mar 2022 | 2 | $0 | 4 | Director | 09 Mar 2022, 16:58 |
| DMAQ | Deep Medicine Acquisition Corp. | 26 Oct 2021 | 0 | $0 | 3 | Director | 26 Oct 2021, 20:28 |